FRAZIER KENNETH C bought EIKN
February 4, 2026 · Form 4 insider transaction
FRAZIER KENNETH C bought 111,111 shares of Eikon Therapeutics, Inc. at $18.00 per share, a transaction worth $2.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
111,111
Price
$18.00
Total value
$2.00M
InsiderFRAZIER KENNETH C
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 4, 2026
Filing dateFebruary 6, 2026
Shares owned after111,111
OwnershipDirect
10b5-1 planNo
AmendedNo